Global Viral Vector and Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Viral Vector and Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Viral Vector and Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Viral Vector and Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Viral Vector and Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Viral Vector and Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Viral Vector and Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Viral Vector and Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Viral Vector and Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ABL, Addgene, Aldevron, Boehringer Ingelheim International GmbH and Brammer Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Viral Vector and Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Viral Vector and Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Viral Vector and Vaccine, with price, sales, revenue and global market share of Viral Vector and Vaccine from 2018 to 2023.
Chapter 3, the Viral Vector and Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Viral Vector and Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Viral Vector and Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Viral Vector and Vaccine.
Chapter 14 and 15, to describe Viral Vector and Vaccine sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Viral Vector and Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Viral Vector and Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Viral Vector and Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Viral Vector and Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Viral Vector and Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Viral Vector and Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Viral Vector and Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ABL, Addgene, Aldevron, Boehringer Ingelheim International GmbH and Brammer Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Viral Vector and Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Adenovirus
- Fowlpox Virus
- Attenuated Yellow Fever
- Vaccinia Virus Vectors
- Research Institutes
- Biopharmaceutical Companies
- Others
- ABL
- Addgene
- Aldevron
- Boehringer Ingelheim International GmbH
- Brammer Bio
- Charles River Laboratories
- Creative-Biogene
- Fujifilm Corporation
- General Electric
- MerckKGaA
- Novasep
- Pfizer
- Spark Therapeutics
- Thermo Fisher Scientific
- Waisman Biomanufacturing
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Viral Vector and Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Viral Vector and Vaccine, with price, sales, revenue and global market share of Viral Vector and Vaccine from 2018 to 2023.
Chapter 3, the Viral Vector and Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Viral Vector and Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Viral Vector and Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Viral Vector and Vaccine.
Chapter 14 and 15, to describe Viral Vector and Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Viral Vector and Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Viral Vector and Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Adenovirus
1.3.3 Fowlpox Virus
1.3.4 Attenuated Yellow Fever
1.3.5 Vaccinia Virus Vectors
1.4 Market Analysis by Application
1.4.1 Overview: Global Viral Vector and Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Research Institutes
1.4.3 Biopharmaceutical Companies
1.4.4 Others
1.5 Global Viral Vector and Vaccine Market Size & Forecast
1.5.1 Global Viral Vector and Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Viral Vector and Vaccine Sales Quantity (2018-2029)
1.5.3 Global Viral Vector and Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 ABL
2.1.1 ABL Details
2.1.2 ABL Major Business
2.1.3 ABL Viral Vector and Vaccine Product and Services
2.1.4 ABL Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 ABL Recent Developments/Updates
2.2 Addgene
2.2.1 Addgene Details
2.2.2 Addgene Major Business
2.2.3 Addgene Viral Vector and Vaccine Product and Services
2.2.4 Addgene Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Addgene Recent Developments/Updates
2.3 Aldevron
2.3.1 Aldevron Details
2.3.2 Aldevron Major Business
2.3.3 Aldevron Viral Vector and Vaccine Product and Services
2.3.4 Aldevron Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Aldevron Recent Developments/Updates
2.4 Boehringer Ingelheim International GmbH
2.4.1 Boehringer Ingelheim International GmbH Details
2.4.2 Boehringer Ingelheim International GmbH Major Business
2.4.3 Boehringer Ingelheim International GmbH Viral Vector and Vaccine Product and Services
2.4.4 Boehringer Ingelheim International GmbH Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
2.5 Brammer Bio
2.5.1 Brammer Bio Details
2.5.2 Brammer Bio Major Business
2.5.3 Brammer Bio Viral Vector and Vaccine Product and Services
2.5.4 Brammer Bio Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Brammer Bio Recent Developments/Updates
2.6 Charles River Laboratories
2.6.1 Charles River Laboratories Details
2.6.2 Charles River Laboratories Major Business
2.6.3 Charles River Laboratories Viral Vector and Vaccine Product and Services
2.6.4 Charles River Laboratories Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Charles River Laboratories Recent Developments/Updates
2.7 Creative-Biogene
2.7.1 Creative-Biogene Details
2.7.2 Creative-Biogene Major Business
2.7.3 Creative-Biogene Viral Vector and Vaccine Product and Services
2.7.4 Creative-Biogene Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Creative-Biogene Recent Developments/Updates
2.8 Fujifilm Corporation
2.8.1 Fujifilm Corporation Details
2.8.2 Fujifilm Corporation Major Business
2.8.3 Fujifilm Corporation Viral Vector and Vaccine Product and Services
2.8.4 Fujifilm Corporation Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Fujifilm Corporation Recent Developments/Updates
2.9 General Electric
2.9.1 General Electric Details
2.9.2 General Electric Major Business
2.9.3 General Electric Viral Vector and Vaccine Product and Services
2.9.4 General Electric Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 General Electric Recent Developments/Updates
2.10 MerckKGaA
2.10.1 MerckKGaA Details
2.10.2 MerckKGaA Major Business
2.10.3 MerckKGaA Viral Vector and Vaccine Product and Services
2.10.4 MerckKGaA Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 MerckKGaA Recent Developments/Updates
2.11 Novasep
2.11.1 Novasep Details
2.11.2 Novasep Major Business
2.11.3 Novasep Viral Vector and Vaccine Product and Services
2.11.4 Novasep Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Novasep Recent Developments/Updates
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Viral Vector and Vaccine Product and Services
2.12.4 Pfizer Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Pfizer Recent Developments/Updates
2.13 Spark Therapeutics
2.13.1 Spark Therapeutics Details
2.13.2 Spark Therapeutics Major Business
2.13.3 Spark Therapeutics Viral Vector and Vaccine Product and Services
2.13.4 Spark Therapeutics Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Spark Therapeutics Recent Developments/Updates
2.14 Thermo Fisher Scientific
2.14.1 Thermo Fisher Scientific Details
2.14.2 Thermo Fisher Scientific Major Business
2.14.3 Thermo Fisher Scientific Viral Vector and Vaccine Product and Services
2.14.4 Thermo Fisher Scientific Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Thermo Fisher Scientific Recent Developments/Updates
2.15 Waisman Biomanufacturing
2.15.1 Waisman Biomanufacturing Details
2.15.2 Waisman Biomanufacturing Major Business
2.15.3 Waisman Biomanufacturing Viral Vector and Vaccine Product and Services
2.15.4 Waisman Biomanufacturing Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Waisman Biomanufacturing Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: VIRAL VECTOR AND VACCINE BY MANUFACTURER
3.1 Global Viral Vector and Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Viral Vector and Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Viral Vector and Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Viral Vector and Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Viral Vector and Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Viral Vector and Vaccine Manufacturer Market Share in 2022
3.5 Viral Vector and Vaccine Market: Overall Company Footprint Analysis
3.5.1 Viral Vector and Vaccine Market: Region Footprint
3.5.2 Viral Vector and Vaccine Market: Company Product Type Footprint
3.5.3 Viral Vector and Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Viral Vector and Vaccine Market Size by Region
4.1.1 Global Viral Vector and Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Viral Vector and Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Viral Vector and Vaccine Average Price by Region (2018-2029)
4.2 North America Viral Vector and Vaccine Consumption Value (2018-2029)
4.3 Europe Viral Vector and Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Viral Vector and Vaccine Consumption Value (2018-2029)
4.5 South America Viral Vector and Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Viral Vector and Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Viral Vector and Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Viral Vector and Vaccine Consumption Value by Type (2018-2029)
5.3 Global Viral Vector and Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Viral Vector and Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Viral Vector and Vaccine Consumption Value by Application (2018-2029)
6.3 Global Viral Vector and Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Viral Vector and Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Viral Vector and Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Viral Vector and Vaccine Market Size by Country
7.3.1 North America Viral Vector and Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Viral Vector and Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Viral Vector and Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Viral Vector and Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Viral Vector and Vaccine Market Size by Country
8.3.1 Europe Viral Vector and Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Viral Vector and Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Viral Vector and Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Viral Vector and Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Viral Vector and Vaccine Market Size by Region
9.3.1 Asia-Pacific Viral Vector and Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Viral Vector and Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Viral Vector and Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Viral Vector and Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Viral Vector and Vaccine Market Size by Country
10.3.1 South America Viral Vector and Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Viral Vector and Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Viral Vector and Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Viral Vector and Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Viral Vector and Vaccine Market Size by Country
11.3.1 Middle East & Africa Viral Vector and Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Viral Vector and Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Viral Vector and Vaccine Market Drivers
12.2 Viral Vector and Vaccine Market Restraints
12.3 Viral Vector and Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Viral Vector and Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Viral Vector and Vaccine
13.3 Viral Vector and Vaccine Production Process
13.4 Viral Vector and Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Viral Vector and Vaccine Typical Distributors
14.3 Viral Vector and Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Viral Vector and Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Viral Vector and Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Adenovirus
1.3.3 Fowlpox Virus
1.3.4 Attenuated Yellow Fever
1.3.5 Vaccinia Virus Vectors
1.4 Market Analysis by Application
1.4.1 Overview: Global Viral Vector and Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Research Institutes
1.4.3 Biopharmaceutical Companies
1.4.4 Others
1.5 Global Viral Vector and Vaccine Market Size & Forecast
1.5.1 Global Viral Vector and Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Viral Vector and Vaccine Sales Quantity (2018-2029)
1.5.3 Global Viral Vector and Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 ABL
2.1.1 ABL Details
2.1.2 ABL Major Business
2.1.3 ABL Viral Vector and Vaccine Product and Services
2.1.4 ABL Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 ABL Recent Developments/Updates
2.2 Addgene
2.2.1 Addgene Details
2.2.2 Addgene Major Business
2.2.3 Addgene Viral Vector and Vaccine Product and Services
2.2.4 Addgene Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Addgene Recent Developments/Updates
2.3 Aldevron
2.3.1 Aldevron Details
2.3.2 Aldevron Major Business
2.3.3 Aldevron Viral Vector and Vaccine Product and Services
2.3.4 Aldevron Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Aldevron Recent Developments/Updates
2.4 Boehringer Ingelheim International GmbH
2.4.1 Boehringer Ingelheim International GmbH Details
2.4.2 Boehringer Ingelheim International GmbH Major Business
2.4.3 Boehringer Ingelheim International GmbH Viral Vector and Vaccine Product and Services
2.4.4 Boehringer Ingelheim International GmbH Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
2.5 Brammer Bio
2.5.1 Brammer Bio Details
2.5.2 Brammer Bio Major Business
2.5.3 Brammer Bio Viral Vector and Vaccine Product and Services
2.5.4 Brammer Bio Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Brammer Bio Recent Developments/Updates
2.6 Charles River Laboratories
2.6.1 Charles River Laboratories Details
2.6.2 Charles River Laboratories Major Business
2.6.3 Charles River Laboratories Viral Vector and Vaccine Product and Services
2.6.4 Charles River Laboratories Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Charles River Laboratories Recent Developments/Updates
2.7 Creative-Biogene
2.7.1 Creative-Biogene Details
2.7.2 Creative-Biogene Major Business
2.7.3 Creative-Biogene Viral Vector and Vaccine Product and Services
2.7.4 Creative-Biogene Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Creative-Biogene Recent Developments/Updates
2.8 Fujifilm Corporation
2.8.1 Fujifilm Corporation Details
2.8.2 Fujifilm Corporation Major Business
2.8.3 Fujifilm Corporation Viral Vector and Vaccine Product and Services
2.8.4 Fujifilm Corporation Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Fujifilm Corporation Recent Developments/Updates
2.9 General Electric
2.9.1 General Electric Details
2.9.2 General Electric Major Business
2.9.3 General Electric Viral Vector and Vaccine Product and Services
2.9.4 General Electric Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 General Electric Recent Developments/Updates
2.10 MerckKGaA
2.10.1 MerckKGaA Details
2.10.2 MerckKGaA Major Business
2.10.3 MerckKGaA Viral Vector and Vaccine Product and Services
2.10.4 MerckKGaA Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 MerckKGaA Recent Developments/Updates
2.11 Novasep
2.11.1 Novasep Details
2.11.2 Novasep Major Business
2.11.3 Novasep Viral Vector and Vaccine Product and Services
2.11.4 Novasep Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Novasep Recent Developments/Updates
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Viral Vector and Vaccine Product and Services
2.12.4 Pfizer Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Pfizer Recent Developments/Updates
2.13 Spark Therapeutics
2.13.1 Spark Therapeutics Details
2.13.2 Spark Therapeutics Major Business
2.13.3 Spark Therapeutics Viral Vector and Vaccine Product and Services
2.13.4 Spark Therapeutics Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Spark Therapeutics Recent Developments/Updates
2.14 Thermo Fisher Scientific
2.14.1 Thermo Fisher Scientific Details
2.14.2 Thermo Fisher Scientific Major Business
2.14.3 Thermo Fisher Scientific Viral Vector and Vaccine Product and Services
2.14.4 Thermo Fisher Scientific Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Thermo Fisher Scientific Recent Developments/Updates
2.15 Waisman Biomanufacturing
2.15.1 Waisman Biomanufacturing Details
2.15.2 Waisman Biomanufacturing Major Business
2.15.3 Waisman Biomanufacturing Viral Vector and Vaccine Product and Services
2.15.4 Waisman Biomanufacturing Viral Vector and Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Waisman Biomanufacturing Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: VIRAL VECTOR AND VACCINE BY MANUFACTURER
3.1 Global Viral Vector and Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Viral Vector and Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Viral Vector and Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Viral Vector and Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Viral Vector and Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Viral Vector and Vaccine Manufacturer Market Share in 2022
3.5 Viral Vector and Vaccine Market: Overall Company Footprint Analysis
3.5.1 Viral Vector and Vaccine Market: Region Footprint
3.5.2 Viral Vector and Vaccine Market: Company Product Type Footprint
3.5.3 Viral Vector and Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Viral Vector and Vaccine Market Size by Region
4.1.1 Global Viral Vector and Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Viral Vector and Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Viral Vector and Vaccine Average Price by Region (2018-2029)
4.2 North America Viral Vector and Vaccine Consumption Value (2018-2029)
4.3 Europe Viral Vector and Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Viral Vector and Vaccine Consumption Value (2018-2029)
4.5 South America Viral Vector and Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Viral Vector and Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Viral Vector and Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Viral Vector and Vaccine Consumption Value by Type (2018-2029)
5.3 Global Viral Vector and Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Viral Vector and Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Viral Vector and Vaccine Consumption Value by Application (2018-2029)
6.3 Global Viral Vector and Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Viral Vector and Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Viral Vector and Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Viral Vector and Vaccine Market Size by Country
7.3.1 North America Viral Vector and Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Viral Vector and Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Viral Vector and Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Viral Vector and Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Viral Vector and Vaccine Market Size by Country
8.3.1 Europe Viral Vector and Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Viral Vector and Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Viral Vector and Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Viral Vector and Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Viral Vector and Vaccine Market Size by Region
9.3.1 Asia-Pacific Viral Vector and Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Viral Vector and Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Viral Vector and Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Viral Vector and Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Viral Vector and Vaccine Market Size by Country
10.3.1 South America Viral Vector and Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Viral Vector and Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Viral Vector and Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Viral Vector and Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Viral Vector and Vaccine Market Size by Country
11.3.1 Middle East & Africa Viral Vector and Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Viral Vector and Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Viral Vector and Vaccine Market Drivers
12.2 Viral Vector and Vaccine Market Restraints
12.3 Viral Vector and Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Viral Vector and Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Viral Vector and Vaccine
13.3 Viral Vector and Vaccine Production Process
13.4 Viral Vector and Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Viral Vector and Vaccine Typical Distributors
14.3 Viral Vector and Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Viral Vector and Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Viral Vector and Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. ABL Basic Information, Manufacturing Base and Competitors
Table 4. ABL Major Business
Table 5. ABL Viral Vector and Vaccine Product and Services
Table 6. ABL Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. ABL Recent Developments/Updates
Table 8. Addgene Basic Information, Manufacturing Base and Competitors
Table 9. Addgene Major Business
Table 10. Addgene Viral Vector and Vaccine Product and Services
Table 11. Addgene Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Addgene Recent Developments/Updates
Table 13. Aldevron Basic Information, Manufacturing Base and Competitors
Table 14. Aldevron Major Business
Table 15. Aldevron Viral Vector and Vaccine Product and Services
Table 16. Aldevron Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Aldevron Recent Developments/Updates
Table 18. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table 19. Boehringer Ingelheim International GmbH Major Business
Table 20. Boehringer Ingelheim International GmbH Viral Vector and Vaccine Product and Services
Table 21. Boehringer Ingelheim International GmbH Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 23. Brammer Bio Basic Information, Manufacturing Base and Competitors
Table 24. Brammer Bio Major Business
Table 25. Brammer Bio Viral Vector and Vaccine Product and Services
Table 26. Brammer Bio Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Brammer Bio Recent Developments/Updates
Table 28. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 29. Charles River Laboratories Major Business
Table 30. Charles River Laboratories Viral Vector and Vaccine Product and Services
Table 31. Charles River Laboratories Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Charles River Laboratories Recent Developments/Updates
Table 33. Creative-Biogene Basic Information, Manufacturing Base and Competitors
Table 34. Creative-Biogene Major Business
Table 35. Creative-Biogene Viral Vector and Vaccine Product and Services
Table 36. Creative-Biogene Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Creative-Biogene Recent Developments/Updates
Table 38. Fujifilm Corporation Basic Information, Manufacturing Base and Competitors
Table 39. Fujifilm Corporation Major Business
Table 40. Fujifilm Corporation Viral Vector and Vaccine Product and Services
Table 41. Fujifilm Corporation Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Fujifilm Corporation Recent Developments/Updates
Table 43. General Electric Basic Information, Manufacturing Base and Competitors
Table 44. General Electric Major Business
Table 45. General Electric Viral Vector and Vaccine Product and Services
Table 46. General Electric Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. General Electric Recent Developments/Updates
Table 48. MerckKGaA Basic Information, Manufacturing Base and Competitors
Table 49. MerckKGaA Major Business
Table 50. MerckKGaA Viral Vector and Vaccine Product and Services
Table 51. MerckKGaA Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. MerckKGaA Recent Developments/Updates
Table 53. Novasep Basic Information, Manufacturing Base and Competitors
Table 54. Novasep Major Business
Table 55. Novasep Viral Vector and Vaccine Product and Services
Table 56. Novasep Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Novasep Recent Developments/Updates
Table 58. Pfizer Basic Information, Manufacturing Base and Competitors
Table 59. Pfizer Major Business
Table 60. Pfizer Viral Vector and Vaccine Product and Services
Table 61. Pfizer Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Pfizer Recent Developments/Updates
Table 63. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 64. Spark Therapeutics Major Business
Table 65. Spark Therapeutics Viral Vector and Vaccine Product and Services
Table 66. Spark Therapeutics Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Spark Therapeutics Recent Developments/Updates
Table 68. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 69. Thermo Fisher Scientific Major Business
Table 70. Thermo Fisher Scientific Viral Vector and Vaccine Product and Services
Table 71. Thermo Fisher Scientific Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Thermo Fisher Scientific Recent Developments/Updates
Table 73. Waisman Biomanufacturing Basic Information, Manufacturing Base and Competitors
Table 74. Waisman Biomanufacturing Major Business
Table 75. Waisman Biomanufacturing Viral Vector and Vaccine Product and Services
Table 76. Waisman Biomanufacturing Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Waisman Biomanufacturing Recent Developments/Updates
Table 78. Global Viral Vector and Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Viral Vector and Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Viral Vector and Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Viral Vector and Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Viral Vector and Vaccine Production Site of Key Manufacturer
Table 83. Viral Vector and Vaccine Market: Company Product Type Footprint
Table 84. Viral Vector and Vaccine Market: Company Product Application Footprint
Table 85. Viral Vector and Vaccine New Market Entrants and Barriers to Market Entry
Table 86. Viral Vector and Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Viral Vector and Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Viral Vector and Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Viral Vector and Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Viral Vector and Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Viral Vector and Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Viral Vector and Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Viral Vector and Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Viral Vector and Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Viral Vector and Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Viral Vector and Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Viral Vector and Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Viral Vector and Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Viral Vector and Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Viral Vector and Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Viral Vector and Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Viral Vector and Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Viral Vector and Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Viral Vector and Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Viral Vector and Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Viral Vector and Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Viral Vector and Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Viral Vector and Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Viral Vector and Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Viral Vector and Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Viral Vector and Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Viral Vector and Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Viral Vector and Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Viral Vector and Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Viral Vector and Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Viral Vector and Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Viral Vector and Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Viral Vector and Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Viral Vector and Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Viral Vector and Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Viral Vector and Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Viral Vector and Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Viral Vector and Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Viral Vector and Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Viral Vector and Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Viral Vector and Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Viral Vector and Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Viral Vector and Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Viral Vector and Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Viral Vector and Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Viral Vector and Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Viral Vector and Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Viral Vector and Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Viral Vector and Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Viral Vector and Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Viral Vector and Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Viral Vector and Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Viral Vector and Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Viral Vector and Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Viral Vector and Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Viral Vector and Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Viral Vector and Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Viral Vector and Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Viral Vector and Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Viral Vector and Vaccine Raw Material
Table 146. Key Manufacturers of Viral Vector and Vaccine Raw Materials
Table 147. Viral Vector and Vaccine Typical Distributors
Table 148. Viral Vector and Vaccine Typical Customers
Table 1. Global Viral Vector and Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Viral Vector and Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. ABL Basic Information, Manufacturing Base and Competitors
Table 4. ABL Major Business
Table 5. ABL Viral Vector and Vaccine Product and Services
Table 6. ABL Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. ABL Recent Developments/Updates
Table 8. Addgene Basic Information, Manufacturing Base and Competitors
Table 9. Addgene Major Business
Table 10. Addgene Viral Vector and Vaccine Product and Services
Table 11. Addgene Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Addgene Recent Developments/Updates
Table 13. Aldevron Basic Information, Manufacturing Base and Competitors
Table 14. Aldevron Major Business
Table 15. Aldevron Viral Vector and Vaccine Product and Services
Table 16. Aldevron Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Aldevron Recent Developments/Updates
Table 18. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table 19. Boehringer Ingelheim International GmbH Major Business
Table 20. Boehringer Ingelheim International GmbH Viral Vector and Vaccine Product and Services
Table 21. Boehringer Ingelheim International GmbH Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 23. Brammer Bio Basic Information, Manufacturing Base and Competitors
Table 24. Brammer Bio Major Business
Table 25. Brammer Bio Viral Vector and Vaccine Product and Services
Table 26. Brammer Bio Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Brammer Bio Recent Developments/Updates
Table 28. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 29. Charles River Laboratories Major Business
Table 30. Charles River Laboratories Viral Vector and Vaccine Product and Services
Table 31. Charles River Laboratories Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Charles River Laboratories Recent Developments/Updates
Table 33. Creative-Biogene Basic Information, Manufacturing Base and Competitors
Table 34. Creative-Biogene Major Business
Table 35. Creative-Biogene Viral Vector and Vaccine Product and Services
Table 36. Creative-Biogene Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Creative-Biogene Recent Developments/Updates
Table 38. Fujifilm Corporation Basic Information, Manufacturing Base and Competitors
Table 39. Fujifilm Corporation Major Business
Table 40. Fujifilm Corporation Viral Vector and Vaccine Product and Services
Table 41. Fujifilm Corporation Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Fujifilm Corporation Recent Developments/Updates
Table 43. General Electric Basic Information, Manufacturing Base and Competitors
Table 44. General Electric Major Business
Table 45. General Electric Viral Vector and Vaccine Product and Services
Table 46. General Electric Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. General Electric Recent Developments/Updates
Table 48. MerckKGaA Basic Information, Manufacturing Base and Competitors
Table 49. MerckKGaA Major Business
Table 50. MerckKGaA Viral Vector and Vaccine Product and Services
Table 51. MerckKGaA Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. MerckKGaA Recent Developments/Updates
Table 53. Novasep Basic Information, Manufacturing Base and Competitors
Table 54. Novasep Major Business
Table 55. Novasep Viral Vector and Vaccine Product and Services
Table 56. Novasep Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Novasep Recent Developments/Updates
Table 58. Pfizer Basic Information, Manufacturing Base and Competitors
Table 59. Pfizer Major Business
Table 60. Pfizer Viral Vector and Vaccine Product and Services
Table 61. Pfizer Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Pfizer Recent Developments/Updates
Table 63. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 64. Spark Therapeutics Major Business
Table 65. Spark Therapeutics Viral Vector and Vaccine Product and Services
Table 66. Spark Therapeutics Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Spark Therapeutics Recent Developments/Updates
Table 68. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 69. Thermo Fisher Scientific Major Business
Table 70. Thermo Fisher Scientific Viral Vector and Vaccine Product and Services
Table 71. Thermo Fisher Scientific Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Thermo Fisher Scientific Recent Developments/Updates
Table 73. Waisman Biomanufacturing Basic Information, Manufacturing Base and Competitors
Table 74. Waisman Biomanufacturing Major Business
Table 75. Waisman Biomanufacturing Viral Vector and Vaccine Product and Services
Table 76. Waisman Biomanufacturing Viral Vector and Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Waisman Biomanufacturing Recent Developments/Updates
Table 78. Global Viral Vector and Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Viral Vector and Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Viral Vector and Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Viral Vector and Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Viral Vector and Vaccine Production Site of Key Manufacturer
Table 83. Viral Vector and Vaccine Market: Company Product Type Footprint
Table 84. Viral Vector and Vaccine Market: Company Product Application Footprint
Table 85. Viral Vector and Vaccine New Market Entrants and Barriers to Market Entry
Table 86. Viral Vector and Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Viral Vector and Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Viral Vector and Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Viral Vector and Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Viral Vector and Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Viral Vector and Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Viral Vector and Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Viral Vector and Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Viral Vector and Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Viral Vector and Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Viral Vector and Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Viral Vector and Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Viral Vector and Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Viral Vector and Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Viral Vector and Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Viral Vector and Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Viral Vector and Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Viral Vector and Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Viral Vector and Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Viral Vector and Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Viral Vector and Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Viral Vector and Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Viral Vector and Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Viral Vector and Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Viral Vector and Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Viral Vector and Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Viral Vector and Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Viral Vector and Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Viral Vector and Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Viral Vector and Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Viral Vector and Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Viral Vector and Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Viral Vector and Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Viral Vector and Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Viral Vector and Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Viral Vector and Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Viral Vector and Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Viral Vector and Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Viral Vector and Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Viral Vector and Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Viral Vector and Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Viral Vector and Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Viral Vector and Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Viral Vector and Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Viral Vector and Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Viral Vector and Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Viral Vector and Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Viral Vector and Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Viral Vector and Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Viral Vector and Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Viral Vector and Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Viral Vector and Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Viral Vector and Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Viral Vector and Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Viral Vector and Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Viral Vector and Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Viral Vector and Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Viral Vector and Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Viral Vector and Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Viral Vector and Vaccine Raw Material
Table 146. Key Manufacturers of Viral Vector and Vaccine Raw Materials
Table 147. Viral Vector and Vaccine Typical Distributors
Table 148. Viral Vector and Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Viral Vector and Vaccine Picture
Figure 2. Global Viral Vector and Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Viral Vector and Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Adenovirus Examples
Figure 5. Fowlpox Virus Examples
Figure 6. Attenuated Yellow Fever Examples
Figure 7. Vaccinia Virus Vectors Examples
Figure 8. Global Viral Vector and Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Viral Vector and Vaccine Consumption Value Market Share by Application in 2022
Figure 10. Research Institutes Examples
Figure 11. Biopharmaceutical Companies Examples
Figure 12. Others Examples
Figure 13. Global Viral Vector and Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Viral Vector and Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Viral Vector and Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Viral Vector and Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Viral Vector and Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Viral Vector and Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Viral Vector and Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Viral Vector and Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Viral Vector and Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Viral Vector and Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Viral Vector and Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Viral Vector and Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Viral Vector and Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Viral Vector and Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Viral Vector and Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Viral Vector and Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Viral Vector and Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Viral Vector and Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Viral Vector and Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Viral Vector and Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Viral Vector and Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Viral Vector and Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Viral Vector and Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Viral Vector and Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Viral Vector and Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Viral Vector and Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Viral Vector and Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Viral Vector and Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Viral Vector and Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Viral Vector and Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Viral Vector and Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Viral Vector and Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Viral Vector and Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Viral Vector and Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 55. China Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Viral Vector and Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Viral Vector and Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Viral Vector and Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Viral Vector and Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Viral Vector and Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Viral Vector and Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Viral Vector and Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Viral Vector and Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Viral Vector and Vaccine Market Drivers
Figure 76. Viral Vector and Vaccine Market Restraints
Figure 77. Viral Vector and Vaccine Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Viral Vector and Vaccine in 2022
Figure 80. Manufacturing Process Analysis of Viral Vector and Vaccine
Figure 81. Viral Vector and Vaccine Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Viral Vector and Vaccine Picture
Figure 2. Global Viral Vector and Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Viral Vector and Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Adenovirus Examples
Figure 5. Fowlpox Virus Examples
Figure 6. Attenuated Yellow Fever Examples
Figure 7. Vaccinia Virus Vectors Examples
Figure 8. Global Viral Vector and Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Viral Vector and Vaccine Consumption Value Market Share by Application in 2022
Figure 10. Research Institutes Examples
Figure 11. Biopharmaceutical Companies Examples
Figure 12. Others Examples
Figure 13. Global Viral Vector and Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Viral Vector and Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Viral Vector and Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Viral Vector and Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Viral Vector and Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Viral Vector and Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Viral Vector and Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Viral Vector and Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Viral Vector and Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Viral Vector and Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Viral Vector and Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Viral Vector and Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Viral Vector and Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Viral Vector and Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Viral Vector and Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Viral Vector and Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Viral Vector and Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Viral Vector and Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Viral Vector and Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Viral Vector and Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Viral Vector and Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Viral Vector and Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Viral Vector and Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Viral Vector and Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Viral Vector and Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Viral Vector and Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Viral Vector and Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Viral Vector and Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Viral Vector and Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Viral Vector and Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Viral Vector and Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Viral Vector and Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Viral Vector and Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Viral Vector and Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 55. China Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Viral Vector and Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Viral Vector and Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Viral Vector and Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Viral Vector and Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Viral Vector and Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Viral Vector and Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Viral Vector and Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Viral Vector and Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Viral Vector and Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Viral Vector and Vaccine Market Drivers
Figure 76. Viral Vector and Vaccine Market Restraints
Figure 77. Viral Vector and Vaccine Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Viral Vector and Vaccine in 2022
Figure 80. Manufacturing Process Analysis of Viral Vector and Vaccine
Figure 81. Viral Vector and Vaccine Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
